NKTR · Forms 3, 4, 5
Insider trades at NEKTAR THERAPEUTICS
2 insiders sold $43K of NEKTAR THERAPEUTICS stock on the open market in the last 90 days.
Every Form 3, 4 and 5 filed for NEKTAR THERAPEUTICS (NKTR) with the SEC, newest first: who traded, their role, buy or sell, shares, price and value.
Insider trades in the last 90 days
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Roy A Whitfield | Director | Award | 2,000 | Form 4 | |||
| R Scott Greer | Director | Award | 2,000 | Form 4 | |||
| Robert Chess | Director | Award | 2,000 | Form 4 | |||
| Diana Brainard | Director | Award | 2,000 | Form 4 | |||
| Jeffrey Robert Ajer | Director | Award | 2,000 | Form 4 | |||
| Jonathan Zalevsky | Chief R&D Officer | Sell | 186 | $71.98 | $13K | Form 4 | |
| Howard W Robin | President & CEO | Sell | 418 | $71.98 | $30K | Form 4 | |
| Jonathan Zalevsky | Chief R&D Officer | Options or other derivatives | Form 4 | ||||
| Howard W Robin | President & CEO | Options or other derivatives | Form 4 |
Buy and Sell are open-market purchases and sales (transaction codes P and S), the trades investors watch. Awards, option exercises, tax withholding and gifts are reported too but are not market trades.